-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

JPMorgan Adjusts NovoCure's Price Target to $99 From $86, Keeps Neutral Rating

JPMorgan Adjusts NovoCure's Price Target to $99 From $86, Keeps Neutral Rating

MT Newswires · 01/06/2023 06:56